Ono warns on profit after govt halves price of cancer drug Opdivo

TOKYO, Dec 21 (Reuters) - Ono Pharmaceutical Co cut

its annual profit outlook by a quarter on Wednesday, hit by the

Japanese government's decision to halve the price of cancer drug

Opdivo that it co-developed with Bristol Myers Squibb Co

.

Read more